New England Journal of Medicine 
Antiviral Treatment for Patients Hospitalized with 2009 Pandemic Influenza A (H1N1)(2)
With the 2009 H1N1 pandemic well under way, many clinicians are providing care to patients with influenza. Previously, although antiviral treatment was recommended,1,2 clinicians may not always have prescribed it to patients hospitalized with seasonal influenza, perhaps because of a perception that antiviral treatment had limited benefit.
Rapid-Test Sensitivity for Novel Swine-Origin Influenza A (H1N1) Virus in Humans
CORRESPONDENCE
Rapid-Test Sensitivity for Novel Swine-Origin Influenza A (H1N1) Virus in Humans
C.C. Blyth, J.R. Iredell, and D.E. Dwyer
Rapid antigen tests, as compared with RT-PCR assays, had poor sensitivity to the 2009 influenza A (H1N1) virus in 21 patients with severe infection and acute lung injury that required mechanical ventilation.
Full Text | PDF
Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis
CORRESPONDENCE
Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis
D.N. Fisman and Others
The results indicate that a neuraminidase mutation (H275Y) is associated with oseltamivir resistance not only in seasonal H1N1 and avian H5N1 viruses but now also in 2009 pandemic H1N1 strains.
Full Text | PDF
Older Age and a Reduced Likelihood of 2009 H1N1 Virus Infection
CORRESPONDENCE
Older Age and a Reduced Likelihood of 2009 H1N1 Virus Infection
D.N. Fisman and Others
Among persons who were at risk for infection with 2009 H1N1 virus, being born before 1957 was associated with a lower infection risk.
Full Text | PDF
More in this category
- Pathological Changes Associated with the 2009 H1N1 Virus
- Preparing for 2009 H1N1 Influenza
- Mandatory Vaccination of Health Care Workers
- The Emergency Use Authorization of Peramivir for Treatment of 2009 H1N1 Influenza
- Use of Ribavirin to Treat Influenza
- A Novel Influenza A (H1N1) Vaccine in Various Age Groups